.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Moodys
McKesson
Colorcon
Argus Health
Covington
Dow
Accenture
Fuji

Generated: June 27, 2017

DrugPatentWatch Database Preview

MINIPRESS XL Drug Profile

« Back to Dashboard

What is the patent landscape for Minipress Xl, and when can generic versions of Minipress Xl launch?

Minipress Xl is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in MINIPRESS XL is prazosin hydrochloride. There are fifteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.

Summary for Tradename: MINIPRESS XL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list98
Clinical Trials: see list1
Patent Applications: see list1,348
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MINIPRESS XL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 1992DISCNNoNo► Subscribe► Subscribe
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-002Jan 29, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MINIPRESS XL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 19924,765,989► Subscribe
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-002Jan 29, 19924,783,337► Subscribe
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 19925,082,668► Subscribe
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 19924,092,315► Subscribe
Pfizer
MINIPRESS XL
prazosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL019775-001Jan 29, 19924,612,008► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Citi
Fuji
Merck
QuintilesIMS
Fish and Richardson
Dow
McKinsey
US Department of Justice
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot